scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M208233200 |
P698 | PubMed publication ID | 12519788 |
P50 | author | Karim Bensaad | Q114431408 |
Morgane Le Bras | Q41585977 | ||
Thierry Soussi | Q43186376 | ||
P2093 | author name string | Giovanni Blandino | |
Sabrina Strano | |||
Dany Rouillard | |||
Osamu Tominaga | |||
Keziban Unsal | |||
P2860 | cites work | p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities | Q22003973 |
p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 | Q22010134 | ||
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage | Q22010200 | ||
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage | Q22010201 | ||
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription | Q24600573 | ||
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
Prediction of complete gene structures in human genomic DNA | Q27860780 | ||
p53, the cellular gatekeeper for growth and division | Q27860990 | ||
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour | Q28118809 | ||
Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis | Q28138604 | ||
Definition of a consensus binding site for p53 | Q28207794 | ||
Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers | Q29616471 | ||
p53: puzzle and paradigm | Q29618407 | ||
p53 family genes: structural comparison, expression and mutation | Q30833177 | ||
A "no-hybrids" screen for functional antagonizers of human p53 transactivator function: dominant negativity in fission yeast. | Q31015221 | ||
Structure, function and regulation of p63 and p73. | Q33818611 | ||
P63 and P73: P53 mimics, menaces and more | Q34185768 | ||
Assessing TP53 status in human tumours to evaluate clinical outcome | Q34570100 | ||
Identification and classification of p53-regulated genes | Q36747355 | ||
AIS is an oncogene amplified in squamous cell carcinoma | Q36978000 | ||
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. | Q38291171 | ||
Regulation of the specific DNA binding function of p53 | Q38324290 | ||
Identification of a sequence element from p53 that signals for Mdm2-targeted degradation | Q39450966 | ||
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain | Q39458140 | ||
p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. | Q39610993 | ||
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy | Q40774297 | ||
Structural aspects of the p53 protein in relation to gene evolution: a second look. | Q41034333 | ||
Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group | Q41227408 | ||
Temperature sensitivity for conformation is an intrinsic property of wild-type p53. | Q42590443 | ||
Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes | Q51231745 | ||
Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein | Q52561980 | ||
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
Small peptides activate the latent sequence-specific DNA binding function of p53. | Q54601436 | ||
Monoclonal antibodies raised against Xenopus p53 interact with human p73 | Q57778803 | ||
Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73 | Q58073315 | ||
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage | Q59065672 | ||
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation | Q70168032 | ||
Flexibility: the key to p53 function? | Q72121789 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10546-10555 | |
P577 | publication date | 2003-01-07 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73 | |
P478 | volume | 278 |
Q38934098 | Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease? |
Q36777361 | Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? |
Q73342473 | Chemosensitivity linked to p73 function |
Q54328419 | Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells |
Q42819037 | Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells |
Q35558858 | Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay |
Q57670523 | Gain of function of mutant p53 by coaggregation with multiple tumor suppressors |
Q37424034 | Mutant p53 mediates survival of breast cancer cells |
Q36661775 | Mutant p53 proteins: between loss and gain of function |
Q36070574 | Mutant p53: one name, many proteins |
Q26749382 | Oncogenic Intra-p53 Family Member Interactions in Human Cancers |
Q39841523 | Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells |
Q36777373 | Reactivation of mutant p53: molecular mechanisms and therapeutic potential |
Q30977773 | Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations |
Q34153014 | The role of mutant p53 in human cancer |
Q36422865 | The role of p73 in hematological malignancies |
Q39005896 | Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. |
Q36436698 | Transcriptional regulation by p53: one protein, many possibilities |
Q37803120 | Translating p53 into the clinic. |
Q40568020 | Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. |
Q37087404 | Versatile functions of p53 protein in multicellular organisms |
Q47223703 | p53 and its family members -- reporter genes may not see the difference |
Q35119547 | p53 mutations and resistance to chemotherapy: A stab in the back for p73 |